Clinical Evaluation of Ropinirole IR Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration).

Trial Profile

Clinical Evaluation of Ropinirole IR Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration).

Discontinued
Phase of Trial: Phase II

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Ropinirole (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Oct 2011 Study terminated due to recruitment problems as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Actual patient number is 34 as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top